Lo KW - Search Results

1

Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells.

Abdul Rahman SF, Azlan A, Lo KW, Azzam G, Mohana-Kumaran N. Abdul Rahman SF, et al. Among authors: lo kw. Discov Oncol. 2022 Feb 3;13(1):9. doi: 10.1007/s12672-022-00470-9. Discov Oncol. 2022. PMID: 35201512 Free PMC article.

2

Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization.

Hui AB, Lo KW, Teo PM, To KF, Huang DP. Hui AB, et al. Among authors: lo kw. Int J Oncol. 2002 Mar;20(3):467-73. Int J Oncol. 2002. PMID: 11836556

3

Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.

Chow LS, Lo KW, Kwong J, Wong AY, Huang DP. Chow LS, et al. Among authors: lo kw. Oncol Rep. 2004 Oct;12(4):781-7. Oncol Rep. 2004. PMID: 15375500

4

Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines.

Or YY, Hui AB, Tam KY, Huang DP, Lo KW. Or YY, et al. Among authors: lo kw. Int J Oncol. 2005 Jan;26(1):49-56. Int J Oncol. 2005. PMID: 15586224

5

14-3-3sigma expression as a prognostic marker in undifferentiated nasopharyngeal carcinoma.

Chan SY, To KF, Leung SF, Yip WW, Mak MK, Chung GT, Lo KW. Chan SY, et al. Among authors: lo kw. Oncol Rep. 2010 Oct;24(4):949-55. doi: 10.3892/or.2010.949. Oncol Rep. 2010. PMID: 20811675

6

Etiological factors of nasopharyngeal carcinoma.

Tsao SW, Yip YL, Tsang CM, Pang PS, Lau VM, Zhang G, Lo KW. Tsao SW, et al. Among authors: lo kw. Oral Oncol. 2014 May;50(5):330-8. doi: 10.1016/j.oraloncology.2014.02.006. Epub 2014 Mar 12. Oral Oncol. 2014. PMID: 24630258

7

The Wnt modulator ICG‑001 mediates the inhibition of nasopharyngeal carcinoma cell migration in vitro via the miR‑150/CD44 axis.

Chan LS, Man OY, Kwok HH, Chen L, Chan KC, Lung HL, Ngan RK, Wong RN, Lo KW, Lee AW, Tsao GS, Kahn M, Lung ML, Mak NK. Chan LS, et al. Among authors: lo kw. Int J Oncol. 2019 Mar;54(3):1010-1020. doi: 10.3892/ijo.2018.4664. Epub 2018 Dec 12. Int J Oncol. 2019. PMID: 30569106

8

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.

Hau PM, Lung HL, Wu M, Tsang CM, Wong KL, Mak NK, Lo KW. Hau PM, et al. Among authors: lo kw. Front Oncol. 2020 May 14;10:600. doi: 10.3389/fonc.2020.00600. eCollection 2020. Front Oncol. 2020. PMID: 32528868 Free PMC article. Review.

9

Nasopharyngeal carcinoma: an evolving paradigm.

Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, Tao Q, Chan KCA, To KF, King AD, Ma BBY, Chan ATC. Wong KCW, et al. Among authors: lo kw. Nat Rev Clin Oncol. 2021 Nov;18(11):679-695. doi: 10.1038/s41571-021-00524-x. Epub 2021 Jun 30. Nat Rev Clin Oncol. 2021. PMID: 34194007 Review.

10

Combinations of indole based alkaloids from Mitragyna speciosa (Kratom) and cisplatin inhibit cell proliferation and migration of nasopharyngeal carcinoma cell lines.

Domnic G, Jeng-Yeou Chear N, Abdul Rahman SF, Ramanathan S, Lo KW, Singh D, Mohana-Kumaran N. Domnic G, et al. Among authors: lo kw. J Ethnopharmacol. 2021 Oct 28;279:114391. doi: 10.1016/j.jep.2021.114391. Epub 2021 Jul 2. J Ethnopharmacol. 2021. PMID: 34224811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page